[Bevacizumab-induced serious heart failure in a patient treated with anthracyclines].
S
S
Fraile Gil
F J
FJ
Hidalgo Correas
M A
MA
Lara Alvarez
F J
FJ
Garrote Martínez
D020533:Angiogenesis Inhibitors / Q000009:adverse effects*; D018943:Anthracyclines / Q000009:adverse effects*; D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D061067:Antibodies, Monoclonal, Humanized; D000068258:Bevacizumab; D001943:Breast Neoplasms / Q000188:drug therapy; D004347:Drug Interactions; D005260:Female; D006333:Heart Failure / Q000139:chemically induced*; D006801:Humans; D008875:Middle Aged; D012720:Severity of Illness Index
D020533:Angiogenesis Inhibitors; D018943:Anthracyclines; D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000068258:Bevacizumab